Data / Form D filings / NUPATHE INC.
NUPATHE INC.: Form D filings
NUPATHE INC., a pharmaceuticals company in Conshohocken, PA, filed 3 Form D notices with the SEC between 2010 and 2012. The latest, on November 6, 2012, reports $28 million sold of a $28 million offering to 20 investors.
Find out what NUPATHE INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 227 WASHINGTON STREET, SUITE 200, Conshohocken, PA, 19428
- Phone
- (484) 567-0130
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1375200
The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 6, 2012 | New notice | $28,000,000 | $28,000,000 | $0 | 20 | Oct 23, 2012 | sec.gov |
| Aug 8, 2011 | New notice | $30,600,000 | $1,100,000 | $29,500,000 | 1 | Aug 2, 2011 | sec.gov |
| Apr 23, 2010 | New notice | $10,062,500 | $10,062,500 | $0 | 10 | Apr 9, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael P. Cola | Director | |
| Gerald W. McLaughlin | Executive Officer | |
| Wayne P. Yetter | Director | |
| Brian J. Sisko | Director | |
| James A. Datin | Director | |
| Michael F. Marino | Executive Officer | |
| Richard S. Kollender | Director | |
| Bart J. Dunn | Executive Officer | |
| Keith A. Goldan | Executive Officer | |
| Terri B. Sebree | Executive Officer | |
| William J. Federici | Director | |
| Armando Anido | Executive Officer, Director | |
| Robert P. Roche | Director |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
Every Form D from the week of Nov 5, 2012 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what NUPATHE INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.